218 related articles for article (PubMed ID: 7790817)
1. Cooperativity between the J and S elements of class II major histocompatibility complex genes as enhancers in normal and class II-negative patient and mutant B cell lines.
Sugawara M; Scholl T; Mahanta SK; Ponath PD; Strominger JL
J Exp Med; 1995 Jul; 182(1):175-84. PubMed ID: 7790817
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
3. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
4. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis.
Bénichou B; Strominger JL
Proc Natl Acad Sci U S A; 1991 May; 88(10):4285-8. PubMed ID: 1852002
[TBL] [Abstract][Full Text] [Related]
5. Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency.
Lennon-Duménil AM; Barbouche MR; Vedrenne J; Prod'Homme T; Béjaoui M; Ghariani S; Charron D; Fellous M; Dellagi K; Alcaïde-Loridan C
J Immunol; 2001 May; 166(9):5681-7. PubMed ID: 11313409
[TBL] [Abstract][Full Text] [Related]
6. Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression.
Sugawara M; Ponath PD; Shin J; Yang Z; Strominger JL
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10347-51. PubMed ID: 1946454
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma response region in the promoter of the class II MHC gene, DPA.
Sugawara M; Ponath PD; Yang Z; Strominger JL
Hum Immunol; 1992 Nov; 35(3):157-64. PubMed ID: 1363420
[TBL] [Abstract][Full Text] [Related]
8. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.
Douhan J; Hauber I; Eibl MM; Glimcher LH
J Exp Med; 1996 Mar; 183(3):1063-9. PubMed ID: 8642248
[TBL] [Abstract][Full Text] [Related]
9. Studies of expression of the DQ beta promoter and its 5' deletion derivatives in normal and mutant human B cell lines.
Sakurai M; Strominger JL
Tissue Antigens; 1989 Jul; 34(1):64-77. PubMed ID: 2510365
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional enhancers in the HLA-DQ subregion.
Sullivan KE; Peterlin BM
Mol Cell Biol; 1987 Sep; 7(9):3315-9. PubMed ID: 3118196
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box.
Ono SJ; Song Z
J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777
[TBL] [Abstract][Full Text] [Related]
12. A factor that regulates the class II major histocompatibility complex gene DPA is a member of a subfamily of zinc finger proteins that includes a Drosophila developmental control protein.
Sugawara M; Scholl T; Ponath PD; Strominger JL
Mol Cell Biol; 1994 Dec; 14(12):8438-50. PubMed ID: 7969177
[TBL] [Abstract][Full Text] [Related]
13. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
[TBL] [Abstract][Full Text] [Related]
14. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
15. Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.
Kovats S; Nepom GT; Coleman M; Nepom B; Kwok WW; Blum JS
J Clin Invest; 1995 Jul; 96(1):217-23. PubMed ID: 7615790
[TBL] [Abstract][Full Text] [Related]
16. cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line.
Freund YR; Dedrick RL; Jones PP
J Exp Med; 1990 Apr; 171(4):1283-99. PubMed ID: 2109037
[TBL] [Abstract][Full Text] [Related]
17. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
[TBL] [Abstract][Full Text] [Related]
18. Mapping cis-acting defects in promoters of transcriptionally silent DQA2, DQB2, and DOB genes.
Voliva CF; Tsang S; Peterlin BM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3408-12. PubMed ID: 8475089
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
20. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family.
Kobr M; Reith W; Herrero-Sanchez C; Mach B
Mol Cell Biol; 1990 Mar; 10(3):965-71. PubMed ID: 2304471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
